Better health and ageing for all Australians

Influenza

Composition of Australian Influenza Vaccine for the 2009 season

This page contains information on the recommended influenza vaccine for the Southern Hemisphere winter 2009.

In this section:

Communicable Diseases Surveillance

The Australian Influenza Vaccine Committee (AIVC) met on 8 October 2008, and agreed to adopt the September WHO recommendations.

The Committee decided that the influenza vaccine components for the year 2009 Season should contain the following:

    • A (H1N1): an A/Brisbane/59/2007 (H1N1) - like strain, 15 µg HA per dose
    • A (H3N2): an A/Brisbane/10/2007 (H3N2) - like strain, 15 µg HA per dose
    • B: a B/Florida/4/2006 - like strain, 15 µg HA per dose
The following viruses are recommended as suitable vaccine strains:
    • A/Brisbane/59/2007 (H1N1) (IVR-148)
    • A/Brisbane/10/2007 (H3N2) (IVR-147) or A/Uruguay/716/2007 (NYMC X -175C)
    • B/Florida /4/2006 or B/Brisbane/3/2007
The SRID reference standard reagents for A/Brisbane/59/2007 (H1N1) (IVR-148) strain are available from TGA or NIBSC (UK).

The SRID reference standard reagents for A/Brisbane/10/2007 (H3N2) (IVR-147) and B/Brisbane/3/2007 strains are available from TGA (Australia).

The SRID reference standard reagents for A/Uruguay/716/2007 (NYMC X -175C) and B/Florida /4/2006 are available from NIBSC.